What is FloShield?
FloShield specializes in the development of advanced laparoscopic vision solutions designed to mitigate common intra-operative challenges. The company's flagship products, including FloShield Air and FloShield Plus, utilize patented Vortex Barrier Technology to maintain clear visualization by shielding laparoscope lenses from condensation, surgical debris, and smoke. By enabling surgeons to perform lens cleaning without the need to remove the scope, FloShield significantly optimizes surgical workflow, reduces procedure duration, and lowers overall healthcare costs. The system's universal compatibility with existing laparoscopic hardware positions it as a versatile and essential tool for modern surgical environments, addressing critical unmet needs in minimally invasive surgery.
How much funding has FloShield raised?
FloShield has raised a total of $15.5M across 3 funding rounds:
Private Equity
$1.4M
Private Equity
$2M
Series C
$12.1M
Private Equity (2008): $1.4M with participation from Canaan Partners, Radius Ventures, and Charter Life Sciences
Private Equity (2010): $2M led by Charter Life Sciences, Canaan Partners, and Radius Ventures
Series C (2015): $12.1M supported by Canaan Partners and Radius Ventures
Key Investors in FloShield
Canaan Partners
Canaan is an early-stage venture capital firm that invests in technology and healthcare companies, backing founders from seed through growth stages in areas such as enterprise software, fintech, consumer, biopharma, and digital health.
Radius Ventures
Radius Ventures was a venture capital firm focused on building innovative companies in the health and life sciences sectors, known for its disciplined, domain-driven investment approach.
Charter Life Sciences
Charter Life Sciences is a life sciences venture capital firm that provides initial capital to companies developing innovative products for significant unmet medical needs.
What's next for FloShield?
With the successful completion of this major strategic investment, FloShield is well-positioned to transition into a phase of accelerated market penetration and product iteration. The company is expected to focus on expanding its distribution channels and deepening its clinical evidence base to support broader adoption in high-volume surgical centers. As the medical device industry continues to prioritize efficiency and patient safety, FloShield's ability to integrate seamlessly into existing surgical workflows provides a distinct competitive advantage. Future strategic initiatives will likely involve scaling manufacturing capabilities to meet rising demand and exploring further innovations in surgical visualization to maintain its leadership position in the life sciences market.
See full FloShield company page
